Investor Relations
If you are a current shareholder and your contact information has changed or you are not getting our updates, please reach out to us at investorrelations@glytecsystems.com
Our Vision
At Glytec, we are revolutionizing the landscape of diabetes care. We envision a world where every instance of patient care is supported by data and actionable insights. We see a future where healthcare decisions are informed, ensuring better, cost-effective care and outcomes for patients and those with diabetes globally.
Glytec’s Industry Leading SaaS Platform
Trusted by 350+ hospitals, empowers collaborative diabetes management and insulin dosing, improving patient outcomes, reducing readmissions, and streamlining workflows while delivering a 6-8x ROI. The first-ever FDA-cleared cloud-based insulin management software is EMR-integrated, easy to set up, and validated by 127 patents and over 100 publications.
The Glytec Glucommander® solution, with clinical decision support, workflow alerts, patient monitoring, at-risk patient identification, and AI-driven analytics, is supported by a mission-driven team dedicated to helping healthcare leaders, clinicians and patients promote health equity and improve diabetes outcomes from hospital to home. We are on a mission, join us.